Inthera Bioscience AG

Venture capital investment in US biopharmaceutical companies slowed in early July as Americans dealt with the awkwardness of celebrating a national holiday right in the middle of the work week by taki

Johnson & Johnson group worldwide chairman Sandra Peterson is leaving the business, effective Oct. 1, after more than five years with the company. Peterson, who reports to CEO and chair of the bo